Veghel, Netherlands

Henricus A Van Den Biggelaar


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1989-1996

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Henricus A Van Den Biggelaar

Introduction

Henricus A Van Den Biggelaar is a notable inventor based in Veghel, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of tableting excipients and lactose formulations. With a total of two patents to his name, his work has had a considerable impact on the industry.

Latest Patents

One of his latest patents is titled "Tableting excipient." This invention focuses on creating a tableting excipient for making tablets through direct tableting. The excipient consists of a homogeneous mass made from a dried solution of lactose with a high beta-lactose content. Additionally, 1-15 wt. % of a sugar alcohol is added to the solution before drying. Another significant patent is "Spray dried lactose and process for preparing the same." This invention relates to a spray-dried lactose that is suitable for use as a component in tablets. The lactose is predominantly crystalline and contains at most 50% by weight of amorphous lactose. The preparation process involves suspending crystalline alpha-lactose hydrate in a saturated lactose solution and includes a spray drying step.

Career Highlights

Henricus has worked with prominent companies in the dairy and pharmaceutical sectors, including DMV Campina B.V. and Campina Melkunie B.V. His experience in these organizations has contributed to his expertise in the development of innovative products.

Collaborations

Throughout his career, Henricus has collaborated with notable colleagues such as Klaas Daniel Kussendrager and Herman Vromans. These partnerships have likely enhanced his research and development efforts.

Conclusion

Henricus A Van Den Biggelaar is a distinguished inventor whose work in tableting excipients and lactose formulations has advanced the pharmaceutical industry. His patents reflect his commitment to innovation and excellence in his field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…